Form 8-K - Current report:
SEC Accession No. 0001641172-25-008830
Filing Date
2025-05-06
Accepted
2025-05-06 16:01:23
Documents
15
Period of Report
2025-05-06
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 51304
2 EX-10.1 ex10-1.htm EX-10.1 44204
  Complete submission text file 0001641172-25-008830.txt   330424

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE afjk-20250506.xsd EX-101.SCH 4019
4 XBRL DEFINITION FILE afjk-20250506_def.xml EX-101.DEF 27090
5 XBRL LABEL FILE afjk-20250506_lab.xml EX-101.LAB 37479
6 XBRL PRESENTATION FILE afjk-20250506_pre.xml EX-101.PRE 25710
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7058
Mailing Address 10 EAST 53RD STREET SUITE 3001 NEW YORK NY 10022
Business Address 10 EAST 53RD STREET SUITE 3001 NEW YORK NY 10022 34 678 035200
Aimei Health Technology Co., Ltd. (Filer) CIK: 0001979005 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41880 | Film No.: 25917084
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)